1. .
   Sex differences in incident atherosclerotic cardiovascular disease events among women and men with HIV: Erratum.
   AIDS 2024;38:935.
   


2. Blot-Cossard A, Merad Y, Bachelard A, Lebreton C, et al.
   Epidemiology and characteristics of Paget's disease of bone in a French nationwide HIV cohort.
   AIDS 2024;38:929-931.
   


3. Barr EA.
   Vespers: A nursing origin story set in the dawn of the HIV pandemic.
   AIDS 2024;38:925-927.
   


4. Feeney ER, Boix V, Hsue PY.
   Chronotropic incompetence in HIV infection.
   AIDS 2024;38:921-923.
   


5. Abdel-Hameed EA, Overton ET.
   What's up with the decline in beans? Are there simple tests to identify people with HIV at risk for chronic kidney disease?
   AIDS 2024;38:917-919.
   


6. Gottert A, Malone S, Pulerwitz J.
   The encouraging early successes of a dynamic choice HIV prevention model for both women and men in East Africa.
   AIDS 2024;38:913-915.
   


7. Oursler KK, Briggs BC, Lozano AJ, Harris NM, et al.
   Association of chronotropic incompetence with reduced cardiorespiratory fitness in older adults with HIV.
   AIDS 2024;38:825-833.
   


8. Li N, Zheng HY, He WQ, He XY, et al.
   Treatment outcomes amongst older people with HIV infection receiving antiretroviral therapy.
   AIDS 2024;38:803-812.
   


9. Jiang J, Wang L, Li Q, Wang Y, et al.
   HIV-1 gp120 amplifies astrocyte elevated gene-1 activity to compromise the integrity of the outer blood-retinal barrier.
   AIDS 2024;38:779-789.
   


10. Saberian C, Lurain K, Hill LK, Marshall V, et al.
    Kaposi sarcoma herpesvirus viral load in bronchoalveolar lavage as a diagnostic marker for pulmonary Kaposi sarcoma.
    AIDS 2024.
    


11. Dirajlal-Fargo S, Yu W, Jacobson DL, Mirza A, et al.
    Gut permeability is associated with lower insulin sensitivity in youth living with perinatally-acquired HIV.
    AIDS 2024.
    


12. Ghassabi F, Hashempour A, Dehghani B, Hasanshahi Z, et al.
    Frequency of Fusion Inhibitor Resistance Mutations Among Therapy-Naive HIV Patients.
    AIDS Res Hum Retroviruses 2024.
    


13. Li Y, Regan M, Swartwood NA, Barham T, et al.
    Disparities in Tuberculosis Incidence by Race and Ethnicity Among the U.S.-Born Population in the United States, 2011 to 2021 : An Analysis of National Disease Registry Data.
    Ann Intern Med 2024.
    


14. Cachay ER, Gilbert T, Qin H, Mathews WC, et al.
    Clinical Predictors and Outcomes of Invasive Anal Cancer for People With Human Immunodeficiency Virus in an Inception Cohort.
    Clin Infect Dis 2024.
    


15. Rodriguez-Molino P, Tebruegge M, Noguera-Julian A, Neth O, et al.
    Tuberculosis disease in immunocompromised children and adolescents: a pTBnet multi-centre case-control study.
    Clin Infect Dis 2024.
    


16. Podany AT, Cramer Y, Imperial M, Rosenkranz SL, et al.
    Twice-Daily Dolutegravir Based Antiretroviral Therapy with One Month of Daily Rifapentine and Isoniazid (1HP) for TB Prevention.
    Clin Infect Dis 2024.
    


17. Tschumi N, Lukau B, Tlali K, Motaboli L, et al.
    Emergence of acquired dolutegravir resistance in treatment-experienced people with HIV in Lesotho.
    Clin Infect Dis 2024.
    


18. Harris E.
    WHO Documents Rising Resistance to First-Line HIV Drug.
    JAMA 2024.
    


19. Erly S, Menza TW, Granillo L, Navejas M, et al.
    Impact of COVID-19 on People Living with HIV: Data from Five Medical Monitoring Project Sites, 2020-2022.
    J Acquir Immune Defic Syndr 2024.
    


20. Bunting SR, Feinstein BA, Vidyasagar N, Sheth NK, et al.
    Psychiatry and Family Medicine Residents' Likelihood of Prescribing HIV Pre-Exposure Prophylaxis (PrEP) to Patients with Mental Illness and HIV Vulnerability.
    J Acquir Immune Defic Syndr 2024.
    


21. Eichholz K, Fukazawa Y, Peterson CW, Haeseleer F, et al.
    Anti-PD-1 chimeric antigen receptor T cells efficiently target SIV-infected CD4+ T cells in germinal centers.
    J Clin Invest 2024;134.
    


22. van Teijlingen NH, van Smoorenburg MY, Sarrami-Forooshani R, Zijlstra-Willems EM, et al.
    Prevotella timonensis bacteria associated with vaginal dysbiosis enhance HIV-1 susceptibility of vaginal CD4+ T cells.
    J Infect Dis 2024.
    


23. Bar Ziv O, Cahn A, Jansen T, Istomin V, et al.
    Diagnosis and Risk Factors of Prediabetes and Diabetes in People Living with HIV- Evaluation of Clinical and Microbiome Parameters.
    J Infect Dis 2024.
    


24. Berenguer J, Jarrin I, Bellon JM, Diez C, et al.
    Mitochondrial Haplogroups and Weight Gain After Initiating ART in Patients with HIV.
    J Infect Dis 2024.
    


25. Jiang X, Gao Z, Sharma PP, Kumar S, et al.
    Discovery of low-molecular-weight phenylalanine derivatives as novel HIV capsid modulators with improved antiretroviral activity and metabolic stability.
    J Med Virol 2024;96:e29594.
    

Display articles in

• Abstract format
• Medline format